BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3663758)

  • 1. [Effect of the lipophilic spin-labeled inhibitor of cytochrome P-450 on the activity of the microsomal system].
    Subkhankulova TN; Liakhovich VV; Vaĭner LM
    Biokhimiia; 1987 Jul; 52(7):1186-91. PubMed ID: 3663758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Affinity modification of membrane-bound microsomal cytochrome P-450 with lipophilic analogs of substrates].
    Subkhankulova TN; Liakhovich VV; Vaĭner LM; Reznikov VA
    Biokhimiia; 1989 Jan; 54(1):17-26. PubMed ID: 2541801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of phospholipids on the differential spectra of the binding of microsomal cytochrome P-450 with substrates].
    Diatlovitskaia EV; Petkova DKh; Lemenovskaia AF; Bergel'son LD
    Biokhimiia; 1984 Apr; 49(4):551-5. PubMed ID: 6733159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of hydroperoxide-dependent reactions with participation of cytochrome P-450.
    Metelitza DI; Akhrem AA; Erjomin AN; Kissel MA; Usanov SA
    Acta Biol Med Ger; 1979; 38(2-3):511-8. PubMed ID: 517012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL; Novak RF
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substrate reduction and oxygen activation during microsomal metabolism of quinones].
    Sushkov DG; Rumiantseva GV; Vaĭner LM
    Biokhimiia; 1987 Nov; 52(11):1898-906. PubMed ID: 2830916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interactions of microsomal cytochrome P-450 with spin-labeled substrate analogs].
    Popova VI; Gapeeva TA; Vaĭner LM; Gorshkova II; Gromova OA
    Biokhimiia; 1983 Jun; 48(6):897-905. PubMed ID: 6309256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of microsomal oxidation by o-benzoquinone derivatives].
    Kostiuk VA
    Biokhimiia; 1987 Mar; 52(3):355-8. PubMed ID: 3580408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
    Alvares AP; Cohn J; Kappas A
    Drug Metab Dispos; 1974; 2(3):259-66. PubMed ID: 4153087
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of phospholipids on the activity of highly-purified liver microsome cytochrome P-450 in a reaction of aniline and naphthalene hydroxylation by hydroperoxides].
    Akhrem AA; Kisel' MA; Usanov SA; Metelitsa DI
    Prikl Biokhim Mikrobiol; 1980; 16(1):100-5. PubMed ID: 6086112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of microsomal cytochromes in the rat liver after intravenous administration of emulsions of perfluoro-organic compounds].
    Obraztsov VV; Shekhtman DG; Sologub GR; Beloiartsev FF
    Biokhimiia; 1985 Jul; 50(7):1220-7. PubMed ID: 4041497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
    Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
    Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxapram inhibits the in vitro oxidation of hexobarbital.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
    Miyazawa M; Shindo M; Shimada T
    Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of quinidine by human liver cytochrome P-450.
    Guengerich FP; Müller-Enoch D; Blair IA
    Mol Pharmacol; 1986 Sep; 30(3):287-95. PubMed ID: 3748010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
    Grubb MF; Diamond S; Christ DD
    Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of phospholipids on cytochrome P-450 and reactions with its participation].
    Metelitsa DI
    Usp Sovrem Biol; 1982; 94(3):345-59. PubMed ID: 6760578
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases.
    Hammons GJ; Guengerich FP; Weis CC; Beland FA; Kadlubar FF
    Cancer Res; 1985 Aug; 45(8):3578-85. PubMed ID: 4016738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.